Drug Makers Gear Up For 2023-2024 COVID-19 Season With Subvariant Vaccines

Pfizer/BioNTech, Moderna, Novavax Work With Regulators

Drug makers are preparing for the 2023-2024 COVID-19 season • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip